Enumera Molecular
Other Health Care company with a recent SEC Form D offering.
Other Health Care company headquartered in ANN ARBOR, MICHIGAN. Filed SEC Form D on 20260731 for a $12.3M Regulation D offering.
Healthcare
📍 ANN ARBOR, MICHIGAN
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Enumera Molecular going public?
No. Enumera Molecular is private and has not filed to go public. There is no S-1 on file.
What is Enumera Molecular's valuation in 2026?
No confirmed valuation is on record for Enumera Molecular. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Enumera Molecular filed an S-1?
No public S-1 is on file for Enumera Molecular.
Can you buy Enumera Molecular stock?
No. Enumera Molecular is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Enumera Molecular on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260731 for $12.3M Regulation D offering
Last Round
Form D filing — $12.33M (20260731)
Fundraising Status
Form D filing · $12.33M
privateTotal raised $12.33M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $12.33M | 20260731 | — | — |
Talent Signal
No public careers page or job board could be found for Enumera Molecular as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
HealthcareForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.